Trial Profile
Quality of Life in Patients With BPH and Nocturia Before and After Tamsulosin Ocas Treatment.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Tamsulosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 25 Dec 2009 Actual patient number (900) added as reported by ClinicalTrials.gov.
- 25 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Jul 2009 Actual initiation date changed from Dec 2008 to Mar 2009 as reported by ClinicalTrials.gov.